NorthStrive Biosciences Signs Definitive License Agreement for Commercialization of EL-22 and EL-32, a Myostatin-Engineered Probiotic for Muscle Preservation in Animal Health
NorthStrive Biosciences Announces Progress Updates to Phase III Timeline for AI-Driven Drug Discovery Program with Yuva Biosciences [Yahoo! Finance]
NorthStrive® Companies Inc. Co-Advises on Acquisition of SVM Machining, Inc. [Yahoo! Finance]
NorthStrive Biosciences Announces Progress Updates to Phase III Timeline for AI-Driven Drug Discovery Program with Yuva Biosciences
PMGC Holdings Inc. Announces the Acquisition of SVM Machining, Inc.